Tizanidine
Product Images NDC 45865-386

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 45865-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tizanidine 2mg 1)

FDA Label Image

Fig1 (Tizanidine 2mg 2)

FDA Label Image

Fig2 (Tizanidine 2mg 3)

Fig2 (Tizanidine 2mg 3)
The text describes the improvement in Ashworth Score by using zanidine with a mean dose of 28.6 mg at week 3 and the end of maintenance endpoint which is Study Week 7. The data were most likely obtained through a study or experiment.*
FDA Label Image

Bottle Of 30 (Tizanidine 2mg 4)

Bottle Of 30 (Tizanidine 2mg 4)
TIZANIDINE HCL TABLETS 2MG is a generic version of Zanarlex and is available in a bottle of 30 tablets. The lot number and NDC code are listed. The medication may cause dizziness and drowsiness, and it is advised not to drive or operate heavy machinery after taking it. The dosage instructions are also included, suggesting to take the tablet(s) a certain number of times per day.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.